NS
SANA icon

NBC Securities’s Sana Biotechnology SANA Stock Holding History

NBC Securities’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26K Buy
9,040
+6,940
+330% +$27.3K ﹤0.01% 1598
2025
Q4 		$8.55K Buy
+2,100
New +$9.4K ﹤0.01% 2068

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

NBC Securities's SANA Position: Q1 2026 in Review

NBC Securities increased its Sana Biotechnology (SANA) stake by 330% in Q1 2026, buying an estimated $27.3K and bringing the position to 9,040 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1598.

NBC Securities first reported a position in SANA in Q4 2025 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • NBC Securities held 9,040 shares of Sana Biotechnology worth $26K as of Q1 2026.
  • NBC Securities bought 6,940 Sana Biotechnology shares in Q1 2026, an estimated $27.3K.
  • Sana Biotechnology made up ﹤0.01% of NBC Securities's portfolio in Q1 2026, its #1598 holding.
  • NBC Securities first reported a position in Sana Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.